Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 3 2015

Print

Search Results for 'biopharma companies'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

By Eric S. Langer, BioPlan Associates
Published June 2, 2015
Downstream purification creating chronic problems Read More »
CRO Outlook & Drug Development Trends
By Kristin Brooks , Contract Pharma
Published May 6, 2015
CRO industry grows as increasingly complex R&D trends demand advanced expertise Read More »
Outsourcing Budgets Continue to Shine
By Eric S. Langer, BioPlan Associates
Published March 6, 2015
Preliminary study data indicates continued spending on outsourcing Read More »
By Brigitte de Lima, Results Healthcare
Published March 6, 2015
A huge opportunity for savvy service providers Read More »
Published March 5, 2015
Employs Total Process Ownership business model Read More »
Published January 29, 2015
Aims to advance technologies and processes for clinical development 
 Read More »
Published December 3, 2014
Responds to stricter guidelines aimed at combatting counterfeit drugs Read More »
Newsmakers: CMOs and CDMOs Have a Trade Association to Call Their Own
Published November 13, 2014
The new Pharma & Biopharma Outsourcing Association aims to help advance the industry’s regulatory, legislative and business interests. Read More »
Clinical Trial Supplies 101: Outsourcing Primer for Virtual Pharma and Biopharma Companies, Part II
By Alex McClung, Xcelience
Published November 13, 2014
Getting packaged investigational materials dispensed to the patients taking part in clinical trials, on time and correctly, requires orchestrating myriad activities. This is the second in a series of articles outlining specific quality concerns associated with packaging clinical trial supplies and how to effectively manage those concerns. Read More »
Published October 30, 2014
Industry veteran Peter Bigelow to guide outsourcing association Board Read More »
Published October 22, 2014
WuXi to perform FoundationOne assay at Shanghai Genome Center Read More »
By Tim Wright, Editor
Published October 14, 2014
As Contract Pharma celebrates its 15th anniversary, where is the industry headed? Read More »
Contract Pharma’s 15th Anniversary Retrospective: Then & Now
By Kristin Brooks, Contract Pharma
Published October 14, 2014
A look back at the pharma/biopharma industry and outsourcing. Read More »
Published September 24, 2014
PBOA to represent CMO/CDMO interests Read More »
Published September 12, 2014
Aims to meet clinical development needs for all therapeutic areas Read More »
Newsmakers: Turning Pharma Supply Chain Management on Its Head
Published September 8, 2014
Models need to be patient-centric, rather than R&D-centric, and a U.K. pilot project may demonstrate what is possible for the industry Read More »
Published September 8, 2014
MAST, a new automated sampling system in late-stage development at Bend Research, aims to eliminate the problems found with today’s autosamplers Read More »
Clinical Trial Supplies 101: An Outsourcing Primer for Virtual Pharma and Biopharma Companies, Part1
By Joseph Iacobucci and Damian Gant , Clinical Supplies and Xcelience
Published September 8, 2014
Getting packaged investigational materials dispensed to the patients taking part in clinical trials, on time and correctly, requires orchestrating myriad activities. Outsourcing makes the process even more complex. This series of articles presents tips on how to do it right. Read More »
Published September 4, 2014
Young brings more than 20 years of experience Read More »
Published August 27, 2014
Training center to aid biopharma companies with manufacturing challenges Read More »
Published August 5, 2014
Partnership establishes global clinical trial network Read More »
Top 25 Pharma and Biopharma Report
Published July 21, 2014
Big Pharma continues to face the impact of competitive pressures, fluctuating currencies, the patent cliff, and pipeline surprises, all of which were reflected in financial results last year. Read More »
Top 25 Pharma and Biopharma Report
Published July 21, 2014
Big Pharma continues to face the impact of competitive pressures, fluctuating currencies, the patent cliff, and pipeline surprises, all of which were reflected in financial results last year.  Payers around the world are demanding lower cost dru… Read More »
By Agnes Shanley, Editor
Published July 21, 2014
Now that FDA has issued draft guidance on social media use, can drug companies come up with deeper, more effective strategies? Read More »
Published July 2, 2014
Reuter responsible for German, Austrian and Swiss markets Read More »
Published June 9, 2014
Anicetti brings 30+ years of quality and regulatory experience Read More »
Can Multivariate Partnerships Streamline Drug Development?
Published June 3, 2014
Quintiles and Biogen Idec enter strategic pact aimed at optimizing Biogen’s clinical development processes Read More »
Published May 16, 2014
Chaplin brings extensive R&D experience in the field oncology Read More »
Published May 9, 2014
Will combine adaptive trial capabilities with ICON’s technology platforms Read More »
Agile Drug Development
By Kristin Brooks , Contract Pharma
Published May 1, 2014
New business models and analytics are driving increased value and efficiency in CRO-sponsor partnerships Read More »
Published April 3, 2014
Catalent, CiRA in regenerative therapy pact Read More »
Published April 3, 2014
AMRI to Acquire Cedarburg Pharma Read More »
Injectables CMOs Stay Ahead of Complexity
By Kristin Brooks , Contract Pharma
Published April 3, 2014
Biologics and cytotoxic processes are pushing demand for specialized contract services, especially from small-to-midsized companies. Read More »
Published March 31, 2014
Expands adaptive trial capabilities Read More »
By Kristin Brooks
Published March 28, 2014
Aims to support new regulatory requirements Read More »
By Kristin Brooks
Published March 12, 2014
Completes $2.65 billion transaction to create global CDMO Read More »
By Kristin Brooks
Published March 11, 2014
Gains access to PBI’s biomarker assays to support clinical testing services Read More »
By Kristin Brooks
Published March 11, 2014
Smyth brings more than 20 years of R&D experience Read More »
Too Much CMO Capacity?
By Eric A. Langer, BioPlan Associates
Published March 7, 2014
A decade ago, there were dire concerns that the biopharmaceutical industry was headed for a severe crisis. There was, it was thought, inadequate mammalian manufacturing capacity to support the development pipeline. In particular, fears grew about sho… Read More »
By Kristin Brooks
Published February 25, 2014
Q&A with Birgit Girshick about the insourcing/outsourcing service for pharma and biopharma Read More »
By Kristin Brooks
Published February 25, 2014
Winter brings 30 years of industry experience Read More »
By Kristin Brooks
Published February 12, 2014
Leverages technologies and product pipelines aimed at advancing therapeutics Read More »
By Gil Roth
Published February 12, 2014
Focuses on three themes, streamlines informatics offerings Read More »
By Kristin Brooks
Published January 21, 2014
Gains approval of Control Testing Lab Read More »
By Kristin Brooks
Published January 8, 2014
Supports more than 300 successful NDAs Read More »
By Kristin Brooks
Published January 7, 2014
Expands integrated commercialization programs for U.S. customers Read More »
Published December 2, 2013
Goldman to establish new partnerships and pursue strategic acquisitions Read More »
Published November 21, 2013
Contract renewal relatively low at 40 to 50% across all product types Read More »
By Kristin Brooks
Published November 6, 2013
Q&A with Ubavka DeNoble, M.D. about small and mid-size company needs Read More »
Published October 28, 2013
Adds 1000L HyClone SUB Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On